EMA's Policy On Proactive Publication Of Clinical Data: First Reports To Be Made Public In Mid-Sept
This article was originally published in SRA
Executive Summary
The European Medicines Agency's policy on proactive publication of clinical trial data from drug applications submitted for approval after January 2015 is expected to result in the first clinical study reports being made public in mid-September. The EMA was earlier aiming to publish the clinical study reports under the policy from mid-20161.